We are live on ! Find out more
INBS icon

Intelligent Bio Solutions
INBS

12 hedge funds and large institutions have $272K invested in Intelligent Bio Solutions in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0% → 0% (-0%)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

8% less funds holding

Funds holding: 13 → 12 (-1)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

35% less capital invested

Capital invested by funds: $416K → $272K (-$144K)

Holders
12
Holders Change
-1
Holders Change %
-7.69%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$32K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$23.6K
3
State Street
State Street
Massachusetts
+$16.9K
4
HF
HRT Financial
New York
+$15.2K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$11.8K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$53.9K
2
BCM
Bridgeway Capital Management
Texas
-$39K
3
Goldman Sachs
Goldman Sachs
New York
-$33K
4
BlackRock
BlackRock
New York
-$24K
5
Citadel Advisors
Citadel Advisors
Florida
-$23K
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
1
Geode Capital Management
Massachusetts
$76K +$1.69K +1 +2%
Renaissance Technologies
2
Renaissance Technologies
New York
$74K +$32K +19 +68%
State Street
3
State Street
Massachusetts
$23K +$16.9K +10 +250%
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$22K +$23.6K +14 New
IWM
5
IHT Wealth Management
Illinois
$13K – – –
HF
6
HRT Financial
New York
$13K +$15.2K +9 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$11K +$11.8K +7 New
Millennium Management
8
Millennium Management
New York
$9K -$10.1K -6 -50%
E
9
Ergoteles
New York
$9K +$10.1K +6 New
UBS Group
10
UBS Group
Switzerland
$8K – – –
VF
11
Virtu Financial
New York
$7K -$53.9K -32 -86%
TSS
12
Two Sigma Securities
New York
$7K -$16.9K -10 -67%
BCM
13
Bridgeway Capital Management
Texas
– -$39K -21 Closed
Goldman Sachs
14
Goldman Sachs
New York
– -$33K -18 Closed
BlackRock
15
BlackRock
New York
– -$24K -13 Closed
Citadel Advisors
16
Citadel Advisors
Florida
– -$23K -12 Closed
TRCT
17
Tower Research Capital (TRC)
New York
– -$3K -2 Closed

INBS Hedge Fund Activity: Q2 2022 in Review

12 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q2 2022, worth a combined $272K — down 35% from $416K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of INBS and 4 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 3 added.

The largest buyer was Renaissance Technologies, adding an estimated $32K. The largest seller was Virtu Financial, cutting an estimated $53.9K.

  • 12 institutional investors held Intelligent Bio Solutions (INBS) as of Q2 2022, down from 13 in Q1 2022.
  • Funds reported $272K of Intelligent Bio Solutions stock for Q2 2022, down 35% quarter-over-quarter.
  • 4 funds opened new Intelligent Bio Solutions positions in Q2 2022 and 5 closed out, a net change of -1 holder.
  • The largest Intelligent Bio Solutions buyer in Q2 2022 was Renaissance Technologies, an estimated $32K added.
  • The largest Intelligent Bio Solutions seller in Q2 2022 was Virtu Financial, an estimated $53.9K sold.

Based on aggregated 13F filings for Q2 2022.